The Emerging Role of Artificial Intelligence in the Fight Against COVID-19

Aruni Ghose, Sabyasachi Roy, Nikhil Vasdev, Jonathon Olsburgh, Prokar Dasgupta, Aruni Ghose, Sabyasachi Roy, Nikhil Vasdev, Jonathon Olsburgh, Prokar Dasgupta

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has generated large volumes of clinical data that can be an invaluable resource towards answering a number of important questions for this and future pandemics. Artificial intelligence can have an important role in analysing such data to identify populations at higher risk of COVID-19-related urological pathologies and to suggest treatments that block viral entry into cells by interrupting the angiotensin-converting enzyme 2-transmembrane serine protease 2 (ACE2-TMPRSS2) pathway.

Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

References

    1. Teoh J.Y., Ong W.L.K., Gonzalez-Padilla D. A global survey on the impact of COVID-19 on urological services. Eur Urol. 2020;78:265–275.
    1. Ribal M.J., Cornford P., Briganti A. European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology guidelines recommendations to the coronavirus disease 2019 era. Eur Urol. 2020;78:21–28.
    1. Menni C., Valdes A.M., Freidin M.B. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26:1037–1040.
    1. Li L., Qin L., Xu Z. Using artificial intelligence to detect COVID-19 and community-acquired pneumonia based on pulmonary CT: evaluation of the diagnostic accuracy. Radiology. 2020;296:E65–71.
    1. Jiang X., Coffee M., Bari A. Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity. Comput Mater Continua. 2020;63:537–551.
    1. Chen L., Liu W., Zhang Q. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect. 2020;9:313–319.
    1. Richardson P., Griffin I., Tucker C. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395:e30–1.
    1. Montopoli M., Zumerle S., Vettor R. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532) Ann Oncol. 2020;31:1040–1045.
    1. Song H., Seddighzadeh B., Cooperberg M.R., Huang F.W. Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells. Eur Urol. 2020;78:296–298.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren